Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

ConclusionThis large-scale real-world data study suggest thatenalapril andcandesartan are associated with a considerable reduction in risk of severe COVID19 outcomes.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research